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ABSTRACT 
An increasing number of non-endemic vectorborne pathogens have been described in dogs 
imported to the UK in the past two decades. Recently, an outbreak of canine babesiosis in 
south-east England has raised veterinary awareness with regard to the impact of such diseases 
on the UK canine population. Canine hepatozoonosis, caused by Hepatozoon canis and 
transmitted by the ingestion of Rhipicephalus sanguineus ticks, is widespread in the 
Mediterranean basin. Herein we describe the first three molecularly confirmed clinical cases 
of canine hepatozoonosis in dogs imported into the UK. Veterinarians in the UK should be 
aware of H. canis as a potential infection in imported dogs, especially in the face of the 
expanding distribution of R. sanguineus ticks in Europe.  
Keywords: hepatozoonosis, Hepatozoon canis, dog, canine tick-borne pathogens, imported 
disease, UK 
  
Introduction 
Hepatozoon canis (Apicomplexa, Adeleorina, Hepatozooidae) is a tick-borne pathogen that 
belongs to a diverse group of parasites which includes approximately 340 species that infect 
a wide range of vertebrates, such as mammals, birds, and reptiles (1). Canine hepatozoonosis 
was first described in India by a British medical officer in 1905 (2) and since then has been 
identified worldwide, with H. canis and Hepatozoon americanum, being of clinical 
importance for dogs (3). These two species differ in geographical distribution, pathogenicity 
and definitive invertebrate host (4). Hepatozoon americanum, is found in the Southern USA 
and causes severe, and often fatal, disease whereas H. canis is present in tropical and sub-
tropical areas globally (5). 
The life cycle for H. canis begins with the ingestion of infected ticks, containing 
sporulated oocysts, by the canine host. Sporozoites are released in the gut, penetrate the 
intestinal epithelium, and disseminate via lymphatics or blood vessels to the haemolymphatic 
tissues (including bone marrow, spleen, and lymph nodes) where they undergo merogony. 
Merozoites are subsequently released and invade leukocytes (neutrophils and monocytes) 
forming gamonts. Gamonts are ingested by ticks during blood feeding, undergo a sexual stage, 
and form oocysts (4, 5). While Rhipicephalus sanguineus (brown dog tick) is considered to 
be the main vector of H. canis, other tick species have been confirmed as definitive vectors 
for this parasite including Amblyomma ovale and Rhipicephalus turanicus (6, 7). 
Transplacental infections of H. canis have also been reported (8), and a recent case-control 
study, using structural equation modelling, found that younger dogs are more likely to be 
infected with H. canis compared to adult dogs (9). Interestingly, H. americanum may 
additionally be spread via ingestion of prey containing the cystozoite stages of the parasite. 
However this mode of transmission has not been evaluated for H. canis (4).  
Clinical signs of H. canis relate to the severity of the parasite burden. It frequently 
causes a chronic sub-clinical infection. Dogs commonly may have a low parasite burden (<1% 
of neutrophils containing gamonts) and be asymptomatic or show only mild clinical signs, 
whereas more severe clinical signs including fever, lethargy and emaciation are noted with 
high parasite burdens (4, 10, 11). In published case reports of dogs suffering from clinical 
signs of H. canis, the percentage of neutrophils containing gamonts varied from 21% to 90% 
(12-14). The commonly reported periostitis caused by H. americanum has also occasionally 
been reported with H. canis, and can be associated with skeletal and muscle pain (8, 14, 15). 
The most common haematological abnormalities associated with H. canis infection 
include mild anaemia and neutrophilia, while rare extreme leukocytosis (up to 150 x109/L 
leukocytes) can occur with high parasitaemia (12-14, 16, 17). Serum biochemistry 
abnormalities typically include hyperproteinaemia with hyperglobulinaemia, 
hypoalbuminaemia, and increased activities of creatine kinase and alkaline phosphatase (4, 
17). 
Infection of dogs with H. canis has been recognised in Asia (13), Europe (18), the 
Mediterranean basin (19-21), the Middle East (17, 22), South America (23), and in the 
southern states of the USA in North America (24). Most recently, H. canis was unexpectedly 
identified for the first time in Queensland, Australia, in an Ixodes holocyclus Neumann tick 
collected from a dog, and the Australian biosecurity authorities are investigating the potential 
sources of this infection (25). The first known case of canine hepatozoonosis in the UK was 
presented in 2011 at the European Society of Veterinary Clinical Pathology congress in a dog 
imported from Ireland (26). Here we further evaluate this case using phylogenetic analysis, 
and we report two additional clinical cases of this infection imported from Cyprus.  
 
Case 1 
A 12-year-old, entire male, Beagle, was presented in September 2010 to a veterinary practice 
in London, UK, having been acquired from a rescue centre in Ireland. There was no clinical 
history available from prior to the Irish rescue centre and no microchip or tattoo was present. 
The dog was presented on the 14th of September 2010 (Day 1), was thin but bright and 
alert. Significant clinical findings included pale mucous membranes, a slightly enlarged 
prostate (presumed to be benign prostatic hyperplasia), occasional cough, slight nasal 
discharge and positive tracheal pinch. Haematology results are shown in Table 1. On Day 1, 
the dog had a mild to moderate, normocytic, normochromic, non-regenerative anaemia. On 
blood smear examination moderate numbers of neutrophils contained intracytoplasmic 
elliptical structures (~9-11µm long, ~4-5µm wide) which were clear to lightly basophilic in 
colour and interpreted as Hepatozoon gamonts (Figures 1 and 2). Hepatozoon gamonts were 
noted in approximately 33% neutrophils. Testing for vector borne diseases (VBD; see 
molecular investigation) revealed infection with H. canis. Serum biochemistry revealed only 
a mild hyperglobulinaemia and mild hypoalbuminaemia. Due to the moderate parasitaemia 
and mild clinical signs, a diagnosis of hepatozoonosis was made. Treatment was initiated with 
imidocarb dipropionate (Imizol® Schering-Plough Animal Health, Darmstadt, Germany; 
6.6mg/kg, by subcutaneous injection, every 14 days) and doxycycline (Ronaxan, Merial, 
Lyon, France; 10mg/kg orally once daily for 28 days). 
Haematology on Day 30 revealed an improvement in the anaemia and a borderline 
monocytosis. Although Hepatozoon gamonts were still present in neutrophils (approximately 
5%), there was reduction in the peripheral parasite burden. Further injections of imidocarb 
dipropionate were administered (total of four injections). At this time, the dog was castrated 
for management of the prostatomegaly. Haematology on Day 44 revealed resolution of the 
anaemia and a mild, novel, neutropenia. No Hepatozoon gamonts were encountered during 
the blood smear examination. 
Two months later (Day 112) haematology demonstrated recurrence of the borderline 
anaemia. Very rare Hepatozoon gamonts were present in neutrophils (<1%). A final course 
of two injections of imidocarb dipropionate (6.6mg/kg, subcutaneously 14 days apart) were 
administered. A final haematology on Day 154 demonstrated continued borderline anaemia 
with slight regeneration and a mild leukopenia. No Hepatozoon gamonts were encountered 
on examination of peripheral blood smears and on buffy coat preparations. This finding was 
supported by conventional PCR analysis for Hepatozoon spp. which was negative. Monthly 
ectoparasitic prevention was recommended for the dog. The dog was doing clinically well 
until the end of 2011 after which time clinical follow up was unavailable. 
 
Case 2 
A five-month-old, entire male, cross-breed, clinically healthy dog was imported into the UK 
from a rescue centre in Paphos, Cyprus (Day 0); the day before travelling it had been treated 
with fipronil and (S)-methoprene spot-on (FrontlineCombo®, Merial, Lyon, France). The dog 
presented to a veterinary practice in Leicester, UK on the 7th of September 2014 (Day 1) due 
to lethargy and presence of tick infestation. Fipronil spray (Frontline® Spray 0.25% w/v 
Cutaneous Spray Solution, Merial) was applied, visible ticks were manually removed and 
disposed of without any further identification. EDTA blood was collected for VBD testing, 
which revealed infection with H. canis.  
The dog's lethargy resolved spontaneously on Day 2. Due to financial limitations, the 
foster owner declined further investigations and treatment. On Day 22, automated 
haematology and serum biochemistry parameters were unremarkable. However, blood smear 
and buffy coat examinations revealed the presence of low numbers Hepatozoon gamonts in 
neutrophils (approximately 8%) (Table 2). Imidocarb dipropionate (6.6 mg/kg, by 
subcutaneous injection, 14 days apart) was administered on Days 22 and 36. On Day 36, the 
dog remained well but low numbers of Hepatozoon gamonts were still visible on blood smear 
examination (<1%) and PCR was positive. Another six injections of imidocarb dipropionate 
(6.6 mg/kg, subcutaneously) were administered weekly. On Day 85 the parasitaemia was not 
apparent on blood smear examination, but PCR remained positive. Monthly ectoparasitic 
prevention was recommended. One and three years following treatment completion, the dog 
was described as healthy by the owner via telephone communication. 
 
Case 3  
An adult, neutered female, Poodle cross, clinically healthy dog was imported into the UK 
from a rescue centre in Paphos, Cyprus (Day 0); the day before travelling it had been treated 
with fipronil and (S)-methoprene spot-on. The dog presented to a veterinary practice in the 
Midlands, UK on the 10th of August 2015 (Day 1) due to anorexia, lethargy and presence of 
ticks which were manually removed and disposed of without any further identification. EDTA 
blood was collected for blood smear examination and VBD testing. On Day 1, the dog had a 
mild neutrophilia and on blood smear examination, moderate numbers of neutrophils 
(approximately 40%) contained Hepatozoon gamonts. Testing for VBD revealed infection 
with H. canis (Table 3). Due to the moderate parasitaemia and mild clinical signs, a diagnosis 
of hepatozoonosis was made. Treatment was initiated with imidocarb dipropionate (6.6 
mg/kg, by subcutaneous injection, 14 days apart, for 8 weeks) and doxycycline (10 mg/kg, 
orally once daily, for 28 days). 
On Day 60 the dog was reported to be clinically healthy by the veterinarian and no 
Hepatozoon gamonts were noted on blood smear examination; however, the dog remained 
PCR positive for H. canis. It was subsequently lost to follow-up and no further clinical 
information was available for this case. 
 
Travel history 
All cases reported here were dogs imported to the UK. The dogs in Cases 2 and 3 were 
imported from Cyprus, a European Union (EU) member island state situated in the eastern 
Mediterranean basin (35°10’N and 33°22’E) with a temperate climate. The predominant tick 
species found in Cyprus is R. sanguineus (27, 28) and a recent study has found that clinically 
healthy dogs from the area of Paphos have a PCR prevalence of 45% for H. canis, 20% for 
Mycoplasma haemocanis, 3% for Anaplasma platys and 1% for Ehrlichia canis (9). 
According to the Ministry of Agriculture, Rural Development and Environment of the 
Republic of Cyprus 8244 dogs travelled from Cyprus to the UK in the years 2015, 2016 and 
2017 with the numbers increasing each year 
(http://www.philenews.com/koinonia/eidiseis/article/536613/steilame-10-850-adespotoys-
skyloys-sto-exoteriko-pinakas). 
 Both Cases 2 and 3, fulfilled all the requirements set by UK’s pet travel scheme 
(PETS) for entering the country, that includes microchip identification, rabies vaccination 21-
days prior to arrival into the UK, and tapeworm treatment administration by a certified vet 
between 5-days and 24-hours prior to arrival into the UK (https://www.gov.uk/take-pet-
abroad). Despite not being a requirement since January 2012, both dogs received acaricide 
treatment 24-hours prior to for entry into the UK, and yet attached ticks were noted upon 
arrival.  
 Case 1 did not have a microchip or a tattoo, making it difficult to trace its movements 
and determine where it became infected with H. canis. Both Ireland and UK were 
considered unlikely countries for acquiring H. canis infection as it has not previously been 
documented in either of these countries and the main vector, R. sanguineus, does not appear 
to be endemic in Ireland or the UK (29, 30). The most common tick encountered in both 
Ireland and the UK is Ixodes ricinus, which has not been shown to be a vector for H. canis 
(29-31). It was considered most likely that Case 1 became chronically infected with H. 
canis in an endemic area, most likely in Southern Europe, possibly in Cyprus (9), France 
(32), Greece (33), Italy (34), Portugal (35) or Spain (36) and then entered Ireland, either 
prior to the introduction of PETS or illegally (37). Another possibility, considered less 
likely, was infection following ingestion of a tick in Ireland that had previously fed on a 
dog infected with H. canis.  
 Molecular investigation, sequencing and phylogenetic analysis 
For all three cases DNA was extracted from 100 L of EDTA-blood using a commercial kit 
(NucleoSpin® Blood, Machery-Nagel, Germany) according to the manufacturer's 
instructions. For the VBD testing, previously described conventional PCR assays , were used 
to detect infection with Ehrlichia/Anaplasma spp. (38) and Hepatozoon spp. (39), and 
quantitative PCR assays were used to detect infection with Leishmania spp. (40), Babesia 
spp.(41), “Candidatus Mycoplasma haematoparvum” and M. haemocanis (42). For each PCR 
assay, appropriate positive and negative controls were included. 
Hepatozoon spp. PCR amplicons were purified using a commercial kit (ExoSAP-IT, 
Affymetrix, USB, Cleveland, Ohio, USA) according to the manufacturer's instructions, and 
the DNA sequenced using forward and reverse primers. The derived sequences were 
assembled using MacVector v15.5.4 (MacVector Inc, Cambridge, UK). DNA sequences were 
deposited in the European Nucleotide Archive. The derived sequence from Case 1 
(LS453286) yielded 100% identity to an existing 18s rRNA gene for H. canis (AF418558) 
over 625 bp. The derived sequences from Cases 2 and 3 (LS453287 and LS453288) yielded 
99% identities to an existing 18s rRNA gene for H. canis (KX818220) over 625 bp and 577 
bp respectively. Sequences obtained in this study were aligned using ClustalW to selected 
18S rRNA gene sequences from Hepatozoon spp. found in GenBank and a phylogenetic tree 
was subsequently generated (Figure 3). All H. canis sequences compared clustered into two 
clades, separate from H. felis, with Cases 2 and 3 separate from Case 1. It was not possible to 
predict the origin of Case 1’s H. canis using available sequence data.  
 
Discussion 
These three cases highlight the risk of introducing non-endemic diseases, such as H. canis 
infection, into the UK through dogs being imported from, or having a travel history to, 
countries where H. canis is endemic. Furthermore, they illustrate the spectrum of 
clinicopathological changes which H. canis infected dogs present with, as well as the 
diagnostic and treatment options available.  
All cases had mild clinical signs that developed shortly after arrival, thus potentially 
the transportation stress may have aided the development of clinical hepatozoonosis from a 
prior sub-clinical infection (43). Only Case 1 displayed mild abnormalities on its haematology 
and biochemistry. Despite the high parasite burden (approximately 33%) a neutrophilia was 
not observed. Indeed, a transient neutropenia was present on Day 44. It is unknown if this was 
related to therapy resulting in the removal of parasitized neutrophils, or whether there was 
underlying inflammation resulting in neutrophil consumption. Dogs with a high parasite 
burden may be at an increased risk of secondary infections. Immune compromise can occur 
for multiple reasons. Neutrophils which contain gamonts have reduced myeloperoxidase 
activity (44), and have been reported to be deficient in oxidative bactericidal capacity (45). 
The mild non-regenerative anaemia noted in this case was attributed to anaemia of 
inflammatory disease, despite the lack of an inflammatory leukogram. The anaemia did 
improve with treatment; however, a borderline anaemia still remained on the final 
haematology. Also, in Case 1 there was a mild hyperglobulinaemia and hypoalbuminaemia, 
as with other reported cases of canine hepatozoonosis due to H. canis (4, 17). The 
hypoalbuminaemia most likely was due to an acute phase protein response or developed in 
compensation to the hyperglobulinaemia, and the hyperglobulinaemia likely reflected chronic 
inflammation. The timing of clinical presentation of all 3 dogs would suggest that they 
became infected during summer when R. sanguineus is most abundant and there is increased 
risk of pathogen transmission (46). Therefore, veterinarians should be aware that dogs 
imported to UK, or having a travel history to, countries where H. canis is endemic during 
summer or early autumn are more likely to have acquired this pathogen compared to dogs 
imported during the winter or spring. Still, given the existence of chronic subclinical infection 
with H. canis, it is possible that dogs imported all year round could develop clinical signs. 
Blood smear examination was the most important diagnostic step in order to identify 
the Hepatozoon gamonts and establish the infection in these three cases. The morphology of 
the gamonts alone cannot distinguish infecting species and given the different prognosis and 
treatment recommendations, PCR and sequencing were performed (4). Interestingly, none of 
the three cases presented here were found to be co-infected with other vector-borne pathogens 
that have frequently been reported in H. canis-infected dogs, such as A. platys, E. canis, or L. 
infantum (21). These other vector-borne pathogens are common in the canine population of 
Cyprus (9, 19, 47) and for Cases 1 and 3 there were clinical concerns initially for E. canis co-
infection, thus doxycycline was administrated. Interestingly, the highest PCR prevalence 
(37.9%) recorded for Hepatozoon felis in cats has been reported in Cyprus, and H. felis 
infected cats are 12 times more likely to be co-infected with Leishmania infantum compared 
to the cats that are PCR negative for H. felis (48, 49). 
Imidocarb dipropionate has been described as the drug of choice for treatment of 
hepatozoonosis caused by H. canis (4). However, as in Cases 2 and 3, imidocarb dipropionate 
has been described as being ineffective in eliminating H. canis infection, despite repeated 
administration over a period of eight months to three naturally infected dogs (34). In all of 
our three cases, treatment resulted in a decrease in the peripheral parasite burden, and eventual 
absence of Hepatozoon gamonts on blood smear examination, and a negative Hepatozoon 
spp. PCR result on blood in Case 1. As PCR was not performed on haemolymphatic tissues, 
complete elimination of the infection could not be confirmed for Case 1. Complete 
elimination of the parasitaemia is difficult to determine on examination of peripheral blood 
smears alone. This is also supported by a published case report of a dog in Japan described as 
having a positive blood PCR for H. canis 242 days after diagnosis, despite an absence of 
gamonts on peripheral blood smear examination (13). In the absence of a more effective 
treatment, imidocarb dipropionate currently remains the drug of choice (6.6 mg/kg, 
subcutaneously 14 days apart) to manage clinical hepatozoonosis due to H. canis, and the 
prognosis is considered good (4).  
We recommend that H. canis positive dogs receive regular and effective ectoparasitic 
prevention to prevent onward transmission and to minimise the risk of acquiring co-infections 
with other vector-borne pathogens, and that they are not used as blood donors. Repeat blood 
smear and buffy coat examinations, as well as PCR’s would be advised every 6-months to 
monitor for parasitaemia, and treatment initiated if clinically warranted (e.g. lethargy, weight 
loss, pyrexia) alongside a positive PCR result or blood smear examination. Administration of 
immunosuppressive or chemotherapeutic agents should be avoided if possible, but if 
necessary, more frequent monitoring of parasitaemia can be performed.  
Hepatozoon species have been previously reported in the UK from pine martens 
(Martes martes) in Scotland (50), wild red squirrels (Sciurus vulgaris) in the Isle of Wight 
(51) and most recently in ticks infesting cats from south-east England for H. felis and from 
Wales for Hepatozoon silvestris (52). Additionally, a letter to Veterinary Record by Skeldon 
et al. described a case of H. canis infection in a dog imported into the UK from Cyprus (53). 
Due to clinical deterioration that dog was euthanised and no further diagnostic tests were 
performed.  
At the moment the risk of H. canis becoming an endemic infection in the canine 
population of UK is low since the current climate does not favour the survival of the main 
vector R. sanguineus (54). However, if climate changes progress to establishing suitable 
conditions for these ticks, then H. canis could potentially become endemic in UK especially 
in the face of the expanding distribution of R. sanguineus ticks in northern Europe (55). The 
recent outbreak of canine babesiosis in UK (56) has raised awareness of the risks associated 
with dog importation and the Public Health England’s Tick Surveillance Scheme’s 
(https://www.gov.uk/guidance/tick-surveillance-scheme) data analysis revealed that dogs 
travelling form Cyprus and Spain may result in  R. sanguineus tick importation (57). 
Rhipicephalus sanguineus ticks can survive and establish populations within houses in the 
UK where canine hosts are present, and could transmit H. canis to other canine hosts within 
such environments (57). Additionally, other potential vector ticks that have not yet been 
investigated may transmit H. canis. In south Hungary, an area considered free from R. 
sanguineus ticks, canine hepatozoonosis has been reported, so Dermacentor marginatus and 
Dermacentor reticulatus ticks that are present there have been considered as possible H. canis 
vectors, although this has not been confirmed (58). Dermacentor reticulatus ticks are present 
in parts of the UK such as western Wales and south-west England, but in small numbers (29) 
so, the overall risk of H. canis transmission in the UK is thought to be very limited. 
These findings, alongside the identification of various non-UK endemic infectious 
pathogens in imported dogs has sparked discussion of altering the current PETS following the 
Brexit referendum (59). Possible reintroduction of a requirement for acaricide treatment of 
dogs by a veterinarian 24-hours prior to entry into the UK has been considered as a measure 
for reducing the risk of tick importation in the UK. Still, it is questionable whether it would 
be effective as demonstrated by Cases 2 and 3 that, despite receiving acaricides prior to 
travelling, both dogs were still found to be infested with ticks upon arrival. A modification of 
this scheme for acaricide treatment of dogs 48-72 hours, followed by examination by a 
veterinarian 24 hours, prior to entry into the UK, to document an apparent absence of ticks 
could also be discussed. Implementing stricter requirements, for example a 10-day quarantine 
facility stay and extensive infectious agent screening such as those in existence in Australia 
(http://www.agriculture.gov.au/cats-dogs/step-by-step-guides/category-3-step-by-step-
guide-for-dogs), could also be explored.  
In the era of increased canine international travel, UK veterinary surgeons and 
diagnosticians should be aware of H. canis infection. Dogs with a travel history from endemic 
countries, especially from Southern Europe, are advised to be molecularly tested for 
Hepatozoon spp. alongside other VBD and blood smear evaluation.  
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Figures and Legends  
 
Figure 1. Case 1, Day 1 blood smear:  Neutrophil containing a Hepatozoon canis 
gamont in the cytoplasm. 100x oil; Modified Wright’s stain.  
 
 
 
 
 
 
 
 
 
  
 
Figure 2. Case 1, Day 1 blood smear: Neutrophils on the feathered edge containing 
numerous Hepatozoon canis gamonts in the cytoplasm. 100x oil; Modified Wright’s 
stain.  
 
 
 
 
 
 
 
  
Figure 3. Phylogenetic tree constructed using the neighbour-joining program, corrected 
for nucleotide substitutions by the Kimura-2 parameter model, in MacVector. The data 
set was resampled 1000 times to generate bootstrap percentages. The country of origin 
is indicated in bold letters for H. canis sequences.  
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 Serial haematology and molecular results from Case 1 (days from initial diagnosis) 
 
Parameter Day 1 Day 30 Day 44 Day 112 Day 154 Reference 
Interval 
Units 
RBC 4.2 5.0 5.2 4.4 4.7 5.5 – 8.5 x1012/L 
HGB 9.8 11.8 12.4 10.6 11.2 12.0 – 18.0 g/dL 
HCT 30.0 35.0 37.0 35.0 38.0 37.0 – 55.0 na 
MCV 70.8 69.7 70.6 80.1* 81.5* 60.0 – 77.0 f/L 
MCH 23.2 23.7 23.9 24.1 23.9 19.5 – 24.5 p/g 
MCHC 32.7 34.0 33.8 30.1 29.4 31.0 – 37.0 g/dL 
WBC 8.0 7.4 8.0 7.3 4.9 6.0 – 17.1 x109/L 
Neutrophils 5.5 3.3 2.6 4.3 3.0 3.0 – 11.5 x109/L 
Lymphocytes 1.3 1.9 2.9 2.0 1.6 1.0 – 4.8 x109/L 
Monocytes 0.8 1.8 1.4 0.7 0.2 0.2 -1.5 x109/L 
Eosinophils 0.4 0.4 1.1 0.4 0.2 0.0 – 1.3 x109/L 
Polychromasia Abs. Mild Mild Abs. Mild na na 
Platelets   114** 249 282   111** 187 150 - 900 x109/L 
Hepatozoon spp. PCR Pos. na na na Neg. na na 
Hepatozoon gamonts 
on blood smear+ 
~33% ~5% Neg. <1% Neg. na na 
Haematology analyses were performed with Cell-DYN 3500 Haematology Analyser (Abbott, Chicago, 
Illinois, United States). 
 
Abnormal findings are denoted by bold font.  
+: % of neutrophils containing H. canis gamonts on the monolayer 
*: In vitro swelling 
**: Moderate platelet clumping, platelet numbers adequate on blood smear examination.  
 
 
Abbreviations: RBC red blood cells; HGB haemoglobin; HCT haematocrit; MCV mean corpuscular volume; 
MCH mean cell haemoglobin; MCHC mean corpuscular haemoglobin concentration; WBC white blood cell; 
Abs. absent; Neg. negative; na not applicable; pos. positive  
 
Table 2 Serial blood smear and molecular results from Case 2 (days from initial presentation) 
 
Parameter Day 1 Day 22 Day 36 Day 85 
Hepatozoon  spp PCR na na Pos. Pos. 
Hepatozoon gamonts 
on blood smear+ 
na ~8% <1% Neg. 
 
Abnormal findings are denoted by bold font.  
+: % of neutrophils containing H. canis gamonts on the monolayer 
 
Abbreviations: na not applicable; Pos. positive; Neg. negative 
 
 
 
 
Table 3 Serial blood smear and molecular results from Case 3 (days from initial diagnosis) 
 
Parameter Day 1 Day 60 
Hepatozoon spp PCR Pos. Pos. 
Hepatozoon gamonts 
on blood smear+ 
~40% Neg. 
 
Abnormal findings are denoted by bold font.  
+: % of neutrophils containing H. canis gamonts on the monolayer 
 
Abbreviations: Pos. positive; Neg. negative 
 
 
 
 
 
 
 
